252 b
Pill imprint 252 b has been identified as Dipyridamole 25 mg.
Dipyridamole is used in the treatment of prosthetic heart valves; radionuclide myocardial perfusion study and belongs to the drug classes cardiac stressing agents, platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Dipyridamole 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Dipyridamole Images
- Imprint:
-
252
b - Strength:
- 25 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
hypromelloses
lactose anhydrous
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
propylene glycol
stearic acid
sodium starch glycolate type A potato
titanium dioxide
- Drug Class:
- Cardiac stressing agents
Platelet aggregation inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0252
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0068 | UDL Laboratories Inc |
| 00904-1086 | Major Pharmaceuticals |
Note: Inactive ingredients may vary.
Advertisement
More Dipyridamole resources
- Dipyridamole (Wolters Kluwer)
- Dipyridamole Tablets (Wolters Kluwer)
- dipyridamole (Cerner Multum)
- dipyridamole Oral, Intravenous (Micromedex) - Includes Dosage Information
- Dipyridamole (AHFS DI)
- Dipyridamole (FDA)
- Dipyridamole Injection (FDA)
- Dipyridamole (Wolters Kluwer)
Search Again
